Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Fitzpatrick, Brian K. [R-PA-1]

Rep. Fitzpatrick, Brian K. [R-PA-1]

United States · Official source

Records

5,907 records where Rep. Fitzpatrick, Brian K. [R-PA-1] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 8471 (119th)referred

PRIMATE Act

United States · United States Congress · 23 April 2026

Bill· HRH.R. 8425 (119th)referred

Strengthening the Vaccines for Children Program Act of 2026

United States · United States Congress · 21 April 2026

Strengthening the Vaccines for Children Program Act of 2026 This bill expands vaccination programs and coverage for children under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, the bill expands and otherwise modifies the Vaccines for Children Program, which provides free vaccinations to individuals 18 years of age or younger who are uninsured or underinsured (i.e., with limited or no insurance for vaccines), are eligible for Medicaid, or are American Indians or Alaskan Natives. The bill expands the program to include children enrolled in CHIP. The Government Accountability Office must report on the related effects of the bill's changes. The bill also temporarily requires payments under Medicaid and CHIP for vaccine administration and counseling services for children to be made at a rate that is no less than the rate under Medicare for equivalent services. It also increases the Federal Medical Assistance Percentage (i.e., federal matching rate) for states that conduct culturally appropriate outreach regarding the benefits of vaccinations for children.

Resolution· HRESH.Res. 1194 (119th)referred

Recognizing April 2026 as "Distracted Driving Awareness Month" and promoting efforts to help prevent tragic and preventable crashes, deaths, and injuries caused by distracted driving.

United States · United States Congress · 20 April 2026

This resolution supports the recognition of Distracted Driving Awareness Month. The resolution also supports the efforts of the Department of Transportation, state and local governments, and state and local law enforcement to prevent and stop distracted driving.

Bill· HRH.R. 8317 (119th)referred

Tech to Save Moms Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8250 (119th)referred

Parents Decide Act

United States · United States Congress · 13 April 2026

Parents Decide Act This bill establishes age-verification requirements for providers of operating systems, which includes software that supports the basic functions of a computer, mobile device, or other general purpose computing device. First, operating system providers must require users to provide their date of birth to set up an account on, and use, the operating system. If the user is under 18 years old, the operating system must require a parent or legal guardian to verify the user's date of birth. Additionally, operating system providers must develop a system to allow app developers to access information necessary to verify the date of birth of a user of the developer's app. The bill provides for enforcement of these requirements by the Federal Trade Commission (FTC). The FTC also must issue regulations on how operating system providers can (1) verify the date of birth of a parent or legal guardian and carry out requirements for verifying the ages of users, (2) secure data collected through the verification process, and (3) ensure parents or legal guardians have control over what users who are under 18 years old are able to access on a device. The FTC must brief Congress on the rulemaking process and report on how operating system providers carry out the requirements of the bill.

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 8209 (119th)open

To amend the Public Health Service Act to reauthorize the school-based health centers grant program.

United States · United States Congress · 6 April 2026

This bill reauthorizes through FY2031 grants from the Health Resources and Services Administration for school-based health centers. School-based health centers are health clinics that are located in or near school facilities, provide primary health care services to children and adolescents during school hours, and are administered by a hospital or certain public or nonprofit entities.

Bill· HRH.R. 8163 (119th)reported

Provider Reimbursement Stability Act of 2026

United States · United States Congress · 30 March 2026

Provider Reimbursement Stability Act of 2026 This bill allows for larger annual adjustments to the Medicare physician fee schedule. It also requires the Centers for Medicare & Medicaid Services (CMS) to make certain corrections to compensate for expenditures under the fee schedule that exceed a certain amount in a given year, and it limits how much certain adjustment factors may vary each year. Current law prohibits annual adjustments to the Medicare physician fee schedule that would result in a more than $20 million difference between the adjusted amount and the non-adjusted amount of total expenditures. The bill increases this threshold to $54.3 million beginning in 2027, with adjustments for inflation every five years beginning in 2032. Additionally, for certain services, the bill requires the CMS to determine the difference between expenditures based on estimated utilization of the service and expenditures based on actual utilization. If this difference exceeds a certain percentage of total expenditures under the fee schedule, the CMS must reconcile this difference by adjusting payments for the following year. This requirement applies to services for which payment was bundled with another service and there was a separate or add-on payment during the previous year. Finally, the CMS must update the prices and rates of each category of direct costs that affect payments (e.g., prices of equipment) at least every five years, with updates made to each category in the same year. The bill also prohibits the CMS from varying a certain adjustment factor by more than 2.5% each year.

Bill· HRH.R. 8122 (119th)referred

9–8–8 Connect Act

United States · United States Congress · 26 March 2026

Bill· HRH.R. 8076 (119th)referred

PREDICT Act

United States · United States Congress · 25 March 2026

Bill· HRH.R. 7906 (119th)referred

FOOD for Health Act

United States · United States Congress · 12 March 2026

Bill· HRH.R. 7879 (119th)referred

SUPER BUGS Act of 2026

United States · United States Congress · 9 March 2026